Literature DB >> 10722434

Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes.

L Harel1, R Straussberg, H Rudich, A H Cohen, J Amir.   

Abstract

Infection with human parvovirus B19 is manifested as erythema infectiosum, transient aplastic crisis, or hydrops fetalis. Rheumatic manifestations include arthropathy and various vasculitic syndromes. Isolated Raynaud's phenomenon due to parvovirus B19 has never been described. We report on 2 previously healthy sisters with new-onset Raynaud's phenomenon accompanied by severe generalized polyarthralgia. A full workup was negative, except serology for parvovirus B19, which was positive. All symptoms gradually subsided within 3-5 months, and no recurrence has been noted during the 3 years since onset. We review all the studies in the English-language literature on parvovirus B19-induced rheumatic and vasculitic syndromes. We hypothesize that the pathogenesis of Raynaud's phenomenon in our patients involved immune-mediated endothelial damage leading to platelet activation and vasoconstriction. We recommend that in cases of unexplained Raynaud's phenomenon, serology for parvovirus B19 be included in the evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722434     DOI: 10.1086/313712

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

Review 1.  Pulmonary hypertension, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

2.  Chikungunya and Neonatal Immunity: Fatal Vertically Transmitted Chikungunya Infection.

Authors:  Tracy Evans-Gilbert
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

Review 3.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

Review 4.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

5.  Primary Raynaud's phenomenon in an infant: a case report and review of literature.

Authors:  Anjali A Sharathkumar; Paul Castillo-Caro
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-18       Impact factor: 3.054

Review 6.  Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.

Authors:  Atiya Dhala
Journal:  Clin Dev Immunol       Date:  2012-03-22

7.  Severe acrocyanosis precipitated by cold agglutinin secondary to infection with Mycoplasma pneumoniae in a pediatric patient.

Authors:  Bernadett Mosdósi; Zoltán Nyul; Arnold Nagy; Kata Bölcskei; Tamás Decsi; Zsuzsanna Helyes
Journal:  Croat Med J       Date:  2017-12-31       Impact factor: 1.351

8.  Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.

Authors:  Hartwig W Lehmann; Annelie Plentz; Philipp von Landenberg; Rolf-M Küster; Susanne Modrow
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 3.650

9.  Fat Embolism Syndrome in Sickle Cell Disease.

Authors:  Dimitris A Tsitsikas; Jessica Vize; Jibril Abukar
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.